© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Prevention
How Well Do U=U and PrEP Work? The CDC Updates Its Answers
#PrEP
#Cure

Is High Cost Hindering Access to Truvada for PrEP?

Total payments for the HIV prevention pill exceeded $2 billion in 2018.

Three Proposed Policy Changes That Impact HIV in the South

HIV efforts in Georgia and Texas could be seriously hindered—but those in Mississippi could be helped.
Outdoor dining on Valencia Street in San Francisco

Is Dining Out a Risk Factor for COVID-19?

A new CDC study leaves the question of indoor versus outdoor dining unanswered.

“Unprecedented” Transmission of Highly Drug-Resistant HIV in France

Researchers are surprised and concerned that a strain of HIV that is so broadly resistant to treatment even has the capacity to transmit.

These HIV Workers Now Fight COVID-19

Staff at San Francisco AIDS Foundation found that many skills, such as delivering HIV test results, translated well.
The National Harm Reduction Coalition revamped its brand and website September 2020

Here’s What the Future of Harm Reduction Looks Like

A revamped National Harm Reduction Coalition tackles the “racist war on drugs” and advocates for people who use drugs.

MUST read

Safer Sex
drug users passing a syringe
Safer Injecting
Treatment-as-Prevention (TasP)

STI Testing Rate for Gay Men on PrEP Is Concerningly Insufficient

This finding calls into question research that has projected that frequent testing among men on PrEP could drive down STI rates.

New Long-Acting Injectable HIV Drug Shows Promise in Monkey Study

The D-peptide HIV entry inhibitor CPT31 is being developed with hopes it could be injected quarterly for both treatment and prevention.
A screenshot of America’s HIV Epidemic Analysis Dashboard (AHEAD)

How to Visually Track Data From the Plan to End the U.S. HIV Epidemic

A digital dashboard displays six gauges in the nation’s effort to lower HIV rates by 90% by 2030.

Washington, DC, Nears Goal of Ending Its HIV Epidemic

Here’s how the nation’s capital remains on track despite COVID-19.

Taking PrEP Only For a Vacation Is an Option for Gay and Bi Men

A study found that men who started PrEP a week before a vacation and stopped a week after coming home adhered well to the daily regimen.

Post-exposure Prophylaxis (PEP)

Pre-exposure Prophylaxis (PrEP)

Experimental HIV Vaccine Stimulates Production of Neutralizing Antibodies

New mRNA vaccine approach protects monkeys from HIV-like virus.

There’s a Long Way to Go to Get the Word Out to Women About PrEP

A study in Chicago, where there has been a considerable effort to educate women about PrEP, found a low level of awareness.

ELEVATE Will Train People Living With HIV for Jobs Ending the Epidemic

A similar training program, ESCALATE, will teach communities to recognize and fight HIV stigma.
Advertisement
Features
Opinions